Celltrion Pharm treasury share disposal of 553 shares for stock option exercise
Celltrion Pharm Inc. filed a treasury share disposal of 553 shares with a planned amount of ₩9m, dated Nov 13, 2026. The disposal is made for the exercise of stock options, through delivery of treasury shares as compensation for the difference.
Key facts
| Planned shares | 553 shares |
|---|---|
| Planned amount | ₩9m |
| Purpose | Exercise of stock options; delivery of treasury shares (difference compensation) |
Comparison
| Amount as % of prior-year revenue (calculated) | less than 0.1% |
|---|---|
| Revenue 2025 | ₩536.4bn |
| Revenue 2024 | ₩477.8bn |
| Revenue 2023 | ₩388.8bn |
Context
By our calculation, the planned amount is less than 0.1% of prior-year revenue. A treasury share disposal transfers shares the company already holds and does not issue new shares. The filing does not state a disposal price per share.
Key metrics
Share buybacks
| Buyback decided, last 3 months | ₩0 |
|---|---|
| Buyback decided, last 3 months, % of shares | 0.0% |
| Shares acquired, last 3 months | ₩0 |
| Shares acquired, last 3 months, % of shares | 0.0% |
| Treasury shares cancelled, last 3 months | ₩0 |
| Treasury shares cancelled (number), last 3 months | 0 shares |
| Treasury shares cancelled, last 3 months, % of shares | 0.0% |
| Buyback decided, last 12 months | ₩0 |
| Buyback decided, last 12 months, % of shares | 0.0% |
| Shares acquired, last 12 months | ₩0 |
| Shares acquired, last 12 months, % of shares | 0.0% |
| Treasury shares cancelled, last 12 months | ₩14.0bn |
| Treasury shares cancelled (number), last 12 months | 149,993 shares |
| Treasury shares cancelled, last 12 months, % of shares | 0.3% |
Source: DART (Financial Supervisory Service) · Original filing on DART ↗